| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/18/2005 | CA2367127C Macrocyclic peptides active against the hepatitis c virus |
| 01/18/2005 | CA2169603C Retrovirus from the hiv group and its use |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/16/2005 | CA2465681A1 The use of conjugated linoleic acid or derivative thereof for the treatment of the common cold |
| 01/13/2005 | WO2005003325A2 Inhibition of viral pathogenesis |
| 01/13/2005 | WO2005003163A1 Sushi peptide multimer |
| 01/13/2005 | WO2005003147A2 Modified fluorinated nucleoside analogues |
| 01/13/2005 | WO2005003111A1 Preventive or remedy for viral conjunctivitis |
| 01/13/2005 | WO2005003087A2 Oxazole derivatives as antibacterial agents |
| 01/13/2005 | WO2005002618A1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 01/13/2005 | WO2005002610A1 Traditional chinese medicine for treating and preventing sars virus |
| 01/13/2005 | WO2005002598A1 Mouth and/or throat wash |
| 01/13/2005 | WO2005002576A2 Imidazole derivatives and their use as protein kinases inhibitors |
| 01/13/2005 | WO2005002561A1 Antifungal agent composition for external use |
| 01/13/2005 | WO2005002552A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 01/13/2005 | WO2005002511A2 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | WO2004106329A3 Novel antiinfective compounds and their pharmaceutical compositions |
| 01/13/2005 | WO2004096197A3 5-aza-7-deazapurine nucleosides for treating flaviviridae |
| 01/13/2005 | WO2004075907A3 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 01/13/2005 | WO2004074807A3 Assay for the identification of protein sic inhibitor |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050010048 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009929 Using terpene compound |
| 01/13/2005 | US20050009902 Treating any types of pruritus such as ocular pruritus, skin pruritus and systemic pruritus with a cannabinoid agonist such as palmidrol and anandamide or a derivative |
| 01/13/2005 | US20050009877 Methods of identifying HCV NS5B polymerase inhibitors and their uses |
| 01/13/2005 | US20050009873 1-Acyl-2,4-dicarbonyldihydropyrrole derivatives, e.g., rel-(2S,5R)-1-(4-tert-butylbenzoyl)-2-isobutyl-5-(1,3-thiazol-2-yl)-2,5-dihydro-1H-pyyrole-2,4-dicarboxylic acid; properation by acylating the corresponding dihydropyrrole derivative |
| 01/13/2005 | US20050009846 2,6,9-Substituted purine derivatives and their use in the treatment of proliferative disorders |
| 01/13/2005 | US20050009843 Thiazole derivatives of pyrido-1,2-a-pyrimidines, quinolones, pyridopyridazinoness, cinnolinones and naphthyridones; identifying a drug efflux pump expressed in a microorganism |
| 01/13/2005 | US20050009842 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009826 5,6,13-trizaza- or 6,13-diazachryseno[2,3-d]-[1,3]dioxole derivatives; enzyme inhibitors; anticarcinogenic, antiproliferative agents; bactericides, fungicides |
| 01/13/2005 | US20050009824 Solubilized topoisomerase poisons |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009802 Tertiary amino-substituted, e.g, 1(4),8(11),15(18),22(25)-tetrakis[(3-(dimethylamino)phenoxy)phthalocyaninato] zinc; and their use as photodynamic therapeutic and photodiagnostic agents. |
| 01/13/2005 | US20050009787 Complex of phosphate and ubiquinone, ascorbic acid, retinol, tocotriennol in mixture with carrier |
| 01/13/2005 | US20050009782 Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof |
| 01/13/2005 | US20050009780 Use of oversulfated polysaccharides as inhibitors of hiv |
| 01/13/2005 | US20050009775 Hepatitis c virus; viricides |
| 01/13/2005 | US20050009764 Therapy for bacteria infections |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009747 High purity lipopeptides |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009743 Analyzing changes in protein; genetic engineering |
| 01/13/2005 | US20050009737 Modified fluorinated nucleoside analogues |
| 01/13/2005 | US20050009682 Antimicrobial alkali-silicate glass ceramic and the use thereof |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009073 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 01/13/2005 | US20050009043 Prodrugs of phosphonate nucleotide analogues |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050008688 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 01/13/2005 | US20050008658 Enterococcus antigens and vaccines |
| 01/13/2005 | US20050008655 Useful as barrier applied to skin; chemical and radiation resistance; skin disorders; autoimmune diseases; antitumor agents; topical applying |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008644 Potentiation of the immune response |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | US20050008631 Anti-hiv and anti-tumor peptides and fragments of lysozyme |
| 01/13/2005 | US20050008614 Herpes virus; papillomas virus; skin; urogenital systems; topical applying; spray dressing |
| 01/13/2005 | US20050008611 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 01/13/2005 | US20050008568 Complex containing dithiocarbamate compound |
| 01/13/2005 | CA2734066A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2734055A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2734052A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2733842A1 Modified fluorinated nucleoside analogues |
| 01/13/2005 | CA2531050A1 Pharmaceutical compounds |
| 01/13/2005 | CA2530797A1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 01/13/2005 | CA2530157A1 Barrier formulation comprising a silicone based emulsion |
| 01/13/2005 | CA2528860A1 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | CA2522329A1 Inhibitors of coronavirus |
| 01/13/2005 | CA2518716A1 Inhibition of viral pathogenesis |
| 01/12/2005 | EP1496109A1 Process for producing cytotoxic lymphocyte |
| 01/12/2005 | EP1495757A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495322A2 Heteroclitic analogs and related methods |
| 01/12/2005 | EP1495141A2 Hiv therapeutic |
| 01/12/2005 | EP1495122A1 Antiviral therapy on the basis of rna interference |
| 01/12/2005 | EP1495110A1 Recombinant spores |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists |
| 01/12/2005 | EP1495042A1 Blanched polyamine steroid derivatives |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495024A1 Dipyridodiazepinones as reverse transcriptase inhibitors |
| 01/12/2005 | EP1495021A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1495001A1 Antibacterial agents |
| 01/12/2005 | EP1494993A2 Novel curcumin analogues and uses thereof |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494749A2 Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability |
| 01/12/2005 | EP1494718A1 Combination of an agent that attenuates topoisomerase i activity and an agent that inhibits heat shock protein 90 for use in chemotherapy |
| 01/12/2005 | EP1494708A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 01/12/2005 | EP1494706A2 Antimicrobial polymer conjugates |
| 01/12/2005 | EP1494703A1 Chemokines mutants having improved oral bioavailability |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494690A2 Cochleates made with purified soy phosphatidylserine |
| 01/12/2005 | EP1494688A1 Use of topical compositions for the control of microbial diseases of the nail |
| 01/12/2005 | EP1494682A2 Polyphosphonate derivatives for toothpaste compositions |